Acro Biomedical Co., Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -1,195.9% | -1,195.9% | -1,011.4% |
| FY2022 | -3,263.2% | -3,263.2% | -2,308.6% |
| FY2023 | 3,426.9% | 3,426.9% | -15,066.2% |
| FY2024 | 14.3% | 14.3% | -132.3% |
| FY2025 | 26.1% | 26.1% | -717.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -1,195.9% | -1,195.9% | -1,011.4% |
| FY2022 | -3,263.2% | -3,263.2% | -2,308.6% |
| FY2023 | 3,426.9% | 3,426.9% | -15,066.2% |
| FY2024 | 14.3% | 14.3% | -132.3% |
| FY2025 | 26.1% | 26.1% | -717.4% |